-
Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside
Xiao, Y., Wang, Q., Zhang, H., Nederlof, R., Bakker, D., Siadari, B. A., Wesselink, M. W., Preckel, B., Weber, N. C., Hollmann, M. W., Schomakers, B. V., van Weeghel, M. & Zuurbier, C. J., Jun 2024, In: Basic Research in Cardiology. 119, 3, p. 403-418 16 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2
Chen, S., Wang, Q., Bakker, D., Hu, X., Zhang, L., van der Made, I., Tebbens, A. M., Kovácsházi, C., Giricz, Z., Brenner, G. B. B., Ferdinandy, P., Schaart, G., Gemmink, A., Hesselink, M. K. C., Rivaud, M. R., Pieper, M. P., Hollmann, M. W., Weber, N. C., Balligand, J-L., Creemers, E. E., & 2 others, 2024, (E-pub ahead of print) In: Basic Research in Cardiology.Research output: Contribution to journal › Article › Academic › peer-review
-
Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2
Chen, S., Wang, Q., Christodoulou, A., Mylonas, N., Bakker, D., Nederlof, R., Hollmann, M. W., Weber, N. C., Coronel, R., Wakker, V., Christoffels, V. M., Andreadou, I. & Zuurbier, C. J., 17 Jan 2023, In: Circulation. 147, 3, p. 276-279 4 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
